Diabetes News and Research

Latest Diabetes News and Research

Light exposure before bedtime may be a easily modifiable risk factor of gestational diabetes

Pregnant persons should dim the lights in their home and turn off or at least dim their screens (computer monitors and smartphones) a few hours before bedtime to reduce the risk of gestational diabetes mellitus, a new Northwestern Medicine study shows.

10 Mar 2023

Dietary polyphenol intake reduces risk of metabolic syndrome

Researchers investigate the relationship between dietary polyphenol intake and metabolic syndrome.

10 Mar 2023

Study explores solutions for advancing health equity through diversifying clinical trials

Despite racial and ethnic minority groups making up nearly half of the United States population, underrepresentation in clinical trials remains a critical challenge.

9 Mar 2023

A small protein could provide a revolutionary approach to tackling obesity-related diseases

Research published today shows that a peptide (small protein) called PEPITEM could provide a revolutionary approach to reducing the risk of type 2 diabetes and other obesity-related diseases such as hepatic steatosis (fatty liver).

9 Mar 2023

New evidence strengthens link between low dose radiation and increased risk of heart disease

Exposure to low doses of ionizing radiation is associated with a modestly increased excess risk of heart disease, finds an analysis of the latest evidence published by The BMJ today.

9 Mar 2023

Researchers develop innovative tool to assess the chances of stroke caused by heart disease

A research team from the Faculty of Medicine and Faculty of Engineering, Chulalongkorn University has jointly developed AICute, an innovative program to assess the chances of stroke caused by heart disease (Ischemic Stroke), aimed at helping hospitals that lack cardiologists to enhance the effectiveness of stroke treatment, reduce congestion in hospitals and medical schools.

9 Mar 2023

Why does insulin cost so much? Big Pharma isn’t the only player driving prices

Eli Lilly & Co.'s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma.

9 Mar 2023

Investigating treat-to-target low-density lipoprotein-cholesterol versus high-intensity statins for coronary artery disease

In a recent study published in JAMA, researchers investigated whether treat-to-target (TTT) low-density lipoprotein-cholesterol (LDL-C) therapy was inferior to administering statins of high intensity for clinical outcomes in the long term among coronary artery disease (CAD) patients.

8 Mar 2023

Study shows correlations between symptoms of long COVID and physical inactivity

The link between symptoms of COVID-19 and physical inactivity is increasingly evident.

8 Mar 2023

Discovery could lead to effective treatments for acute alcohol intoxication

A shot of a liver-produced hormone called FGF21 sobered up mice that had passed out from alcohol, allowing them to regain consciousness and coordination much faster than those that didn't receive this treatment, UT Southwestern researchers report in a new study.

8 Mar 2023

Dementia the strongest risk factor for infection with COVID-19 in older people

In 2020, the first year of the COVID-19 pandemic, dementia was the dominant risk factor for the disease among residents of Swedish nursing homes.

8 Mar 2023

Does treatment status relate to other diseases in gout patients?

A new study shows how urate-lowering therapy (ULT) is related to such conditions as chronic kidney disease (CKD) and cardiovascular disease (CVD).

8 Mar 2023

The importance of ketones from a clinical and medical perspective

In this interview, News-Medical talks to Marcin Pacek, senior director of medical and scientific affairs in Europe for Nova Biomedical, about the importance of ketones in a medical and clinical setting.

From Nova Biomedical 8 Mar 2023

Statin-related residual inflammation predicts cardiovascular events and mortality

A recent Lancet study assessed the importance of low-density lipoprotein cholesterol (LDLC) and high-sensitivity C-reactive protein (CRP) as risk predictors of cardiovascular death, cardiovascular events, and all-cause death among patients subjected to statins.

7 Mar 2023

Additive effects of genetic, socioeconomic factors account for the prevalence of type 2 diabetes and obesity

New research led by investigators at Massachusetts General Hospital, a founding member of Mass General Brigham, indicates that socioeconomic and genetic factors likely interact in an additive way to affect people's risks of developing obesity and type 2 diabetes.

7 Mar 2023

Study paves the way to new sex-specific anti-obesity drugs

Sex differences exist in the regulation of energy homeostasis, the organism's mechanism to keep a stable body weight. Current studies indicate for instance that female mammals, including humans, are better protected against metabolic diseases during reproductive age.

7 Mar 2023

Research helps explain the metabolic differences of people living at high altitudes

Compared to those of us who live at sea level, the 2 million people worldwide who live above 4,500 meters (or 14,764 feet) of elevation-;about the height of Mount Rainier, Mount Whitney, and many Colorado and Alaska peaks-;have lower rates of metabolic diseases such as diabetes, coronary artery disease, hypercholesterolemia, and obesity.

7 Mar 2023

Long-term intermittent fasting can offer protection from heart-related COVID-19 complications

Intermittent fasting, especially when done over the course of decades, can have positive effects on metabolic and cardiovascular health.

7 Mar 2023

Exploring adverse outcomes in post-COVID-19 condition patients

In a recent study published in the JAMA Health Forum, researchers assessed the adverse outcomes observed among post-coronavirus disease 2019 (COVID-19) condition (PCC) patients as compared to non-COVID-19 (NC) persons.

7 Mar 2023

Prevalence and clinical outcomes of viral and bacterial coinfections in hospitalized COVID-19 patients

In a recent study, researchers analyzed the occurrence of bacterial and viral infections in adults hospitalized with coronavirus disease 2019 (COVID-19) to determine the clinical and demographic features, outcomes, and microbial spectrums associated with bacterial coinfections and the prevalence of viral coinfections.

7 Mar 2023

Diabetes News and Research

Latest Diabetes News and Research

Light exposure before bedtime may be a easily modifiable risk factor of gestational diabetes

Dietary polyphenol intake reduces risk of metabolic syndrome

Study explores solutions for advancing health equity through diversifying clinical trials

A small protein could provide a revolutionary approach to tackling obesity-related diseases

New evidence strengthens link between low dose radiation and increased risk of heart disease

Researchers develop innovative tool to assess the chances of stroke caused by heart disease

Why does insulin cost so much? Big Pharma isn’t the only player driving prices

Investigating treat-to-target low-density lipoprotein-cholesterol versus high-intensity statins for coronary artery disease

Study shows correlations between symptoms of long COVID and physical inactivity

Discovery could lead to effective treatments for acute alcohol intoxication

Dementia the strongest risk factor for infection with COVID-19 in older people

Does treatment status relate to other diseases in gout patients?

The importance of ketones from a clinical and medical perspective

Statin-related residual inflammation predicts cardiovascular events and mortality

Additive effects of genetic, socioeconomic factors account for the prevalence of type 2 diabetes and obesity

Study paves the way to new sex-specific anti-obesity drugs

Research helps explain the metabolic differences of people living at high altitudes

Long-term intermittent fasting can offer protection from heart-related COVID-19 complications

Exploring adverse outcomes in post-COVID-19 condition patients

Prevalence and clinical outcomes of viral and bacterial coinfections in hospitalized COVID-19 patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diabetes News and Research

Latest Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in